Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'26 Budget'24
  • Budget'25 Budget'24
    • Home
    • News

    Paytm Shares Plunge 20% as RBI Imposes Restrictions on Lending Business


    Finance Outlook India Team | Thursday, 01 February 2024

    Paytm shares witnessed a sharp decline of 20% in early trading on February 1, plummeting to the lower circuit, following significant restrictions imposed by the Reserve Bank of India (RBI) on the company's lending operations. These restrictions include a ban on accepting new deposits and conducting credit transactions after February 29.

    Opening at the lower circuit at Rs 609 per share, the fintech giant's stock experienced a substantial drop compared to the previous day's closing price of Rs 761 on the NSE. Year-to-date, the stock has incurred a 1% loss, while in 2023, it saw a notable decline of 27.45%. Mutual funds held a 5% stake in Paytm as of the December 2023 quarter, up from 2.79% in the preceding quarter.

    The RBI's action was prompted by a validation report from external auditors, revealing persistent non-compliance and ongoing material supervisory concerns within Paytm Payments Bank. In response to the regulatory measures, Paytm promptly communicated its commitment to complying with RBI directives, including collaborative efforts to swiftly address concerns.

    Acknowledging the potential impact, Paytm informed exchanges that, depending on the resolution's nature, the worst-case scenario could result in an annual EBITDA impact ranging from Rs 300-500 crore. Despite these challenges, the company expressed confidence in its ability to continue improving profitability.

    Moreover, Paytm clarified to exchanges that its founder, Vijay Shekhar Sharma, has not taken any margin loans or pledged shares directly or indirectly owned by him. Sharma, currently Paytm's largest shareholder and Significant Beneficial Owner, acquired a 10% stake from AntFin in August 2023 through his wholly-owned overseas entity, Resilient Asset Management BV, elevating his holding to 19.42%.

    In response to the regulatory developments, brokerage firm Jefferies downgraded Paytm from a 'buy' to 'underperform' and slashed the stock's price target by more than half to Rs 500. The downgrade reflects concerns about significant reputational risks for Paytm following the RBI's stringent measures. Jefferies' revised target price suggests a downside potential of over 34% for Paytm's stock.



    Read More:

    ConvoZen Launches End-to-End Conversational AI

    India & France Revise Tax Treaty, Scrap MFN Clause, Ease Dividends

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25